177lu-dotatate in patients with well-differentiated, high-grade nets
Published 1 year ago • 115 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:59
netter-1 update: 177lu-dotatate in patients with midgut neuroendocrine tumors
-
4:25
final os from netter-1: lutetium-177-dotatate in patients with midgut nets
-
1:41
dr. jonathan r. strosberg on 177-lu-dotatate in patients with neuroendocrine tumors
-
0:48
netter-2: 177lu-dotatate in gastroenteropancreatic nets
-
2:16
dr. strosberg on quality of life findings for lu-dotatate in patients with midgut nets
-
13:35
abcs of neuroendocrine cancer: 2020 update
-
42:05
netwise episode 1 refresh: what you need to know about nets & necs.
-
5:38
symptoms types and diagnosis of neuroendocrine tumours (nets)
-
3:09
new treatment for neuroendocrine tumors
-
2:03
current treatment options for patients with nets
-
1:19
dr. strosberg on future of 177lu-dotatate therapy in neuroendocrine tumors
-
2:13
understanding neuroendocrine tumors
-
23:34
netter 1 phase iii in patients with midgut neuroendocrine tumors treated with 177lu dotatate efficac
-
3:04
unmet needs in nets
-
5:53
phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors
-
35:27
radioisotopic targeting of nets lutetium 177 dotatate and what does future hold? - eric liu, md
-
2:26
what can we offer for patients with neuroendocrine tumours (nets)?
-
42:37
radioisotopic targeting of nets: lutetium-177 dotatate and what does the future hold? by dr.bushnell
-
16:55
pathological classification of net
-
58:27
pancreatic neuroendocrine tumors
-
15:19
panel: neuroendocrine tumors 101 - a primer